Vaccine Hesitancy: A Survey of Pediatric Clinicians
NCT01098825 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2011-06-27
Summary
The purpose of this study is to explore the experiences and perceptions of District VI pediatric clinicians on parental vaccine hesitancy and vaccine refusal.
Conditions
- Vaccine Hesitancy
- Vaccine Refusal
Interventions
- OTHER
-
web-based survey
Anonymous web-based survey
Sponsors & Collaborators
-
Children's Mercy Hospital Kansas City
lead OTHER
Principal Investigators
-
Christopher J Harrison, MD · Children's Mercy Hospital Kansas City
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-04-30
- Primary Completion
- 2010-10-31
- Completion
- 2010-10-31
Countries
- United States
Study Locations
More Related Trials
-
Dose Comparison Study of Menactra® in US Children
NCT00700635 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.
NCT01682876 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers
NCT00667602 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine
NCT01939158 ·Status: COMPLETED ·Phase: PHASE3
-
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
NCT06603090 ·Status: COMPLETED ·Phase: NA
-
A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years
NCT02531698 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers
NCT01049035 ·Status: COMPLETED ·Phase: PHASE2
-
Educational Videos to Address Vaccine Hesitancy in Childhood Immunization
NCT05390697 ·Status: COMPLETED ·Phase: NA
-
Improving Vaccine Counseling Skills Among Residents Using Educational Modules and Standardized Patient Encounters
NCT06074237 ·Status: COMPLETED ·Phase: NA
-
A Single-center, Open Trials to Evaluate the Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine
NCT02481232 ·Status: UNKNOWN ·Phase: PHASE1
-
Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): Its' Correlation Factors and an Educational Intervention Programme
NCT04930185 ·Status: UNKNOWN ·Phase: NA
-
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months
NCT05229536 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age
NCT00310635 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
NCT06350058 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Persistence of Immunogenicity of MenACWY Conjugate Vaccine 5 Years After Childhood Vaccination, and Immune Response to a Booster Dose
NCT01823536 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
NCT00806195 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
NCT02140762 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine
NCT04689191 ·Status: UNKNOWN ·Phase: PHASE3
-
Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.
NCT02534935 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the ACYW135 Meningococcal Polysaccharide Conjugate Vaccine
NCT06337071 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)
NCT00310856 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants
NCT00161928 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents
NCT02285777 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children
NCT00262028 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age
NCT00643916 ·Status: COMPLETED ·Phase: PHASE2